These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26791289)

  • 1. Special Issue--Towards Understanding the Mechanisms and Curing of Muscular Dystrophy Diseases.
    Phylactou LA
    Molecules; 2015 Jul; 20(7):12944-5. PubMed ID: 26791289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular dystrophies: histology, immunohistochemistry, molecular genetics and management.
    Costanza L; Moggio M
    Curr Pharm Des; 2010; 16(8):978-87. PubMed ID: 20041828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limb-girdle muscular dystrophies.
    Piccolo F; Moore SA; Mathews KD; Campbell KP
    Adv Neurol; 2002; 88():273-91. PubMed ID: 11908231
    [No Abstract]   [Full Text] [Related]  

  • 4. Skeletal muscle in health and disease.
    Morgan J; Partridge T
    Dis Model Mech; 2020 Feb; 13(2):. PubMed ID: 32066552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating muscular dystrophy by stimulating intrinsic repair.
    Wang YX; Bentzinger CF; Rudnicki MA
    Regen Med; 2013 May; 8(3):237-40. PubMed ID: 23627818
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary muscular dystrophies and the heart.
    Hermans MC; Pinto YM; Merkies IS; de Die-Smulders CE; Crijns HJ; Faber CG
    Neuromuscul Disord; 2010 Aug; 20(8):479-92. PubMed ID: 20627570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of caveolin-3 protein is limited in damaged muscle in chicken muscular dystrophy.
    Matsumoto H; Sasazaki S; Fujiwara A; Ichihara N; Kikuchi T; Mannen H
    Comp Biochem Physiol A Mol Integr Physiol; 2010 Sep; 157(1):68-72. PubMed ID: 20451648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
    Sundaram C; Vydehi B; Meena K; Murthy J
    Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Strategies of Muscular Dystrophy Therapeutics: An Overview.
    Lim KRQ; Yokota T
    Methods Mol Biol; 2023; 2587():3-30. PubMed ID: 36401021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Pathological Activities of CCN2/CTGF in Muscle Dystrophy.
    Acuña MJ; Brandan E
    Methods Mol Biol; 2017; 1489():513-521. PubMed ID: 27734402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscular dystrophy: new opportunities for diagnosis and treatment.
    Babcock MA; Kostova FV; Moxley RT; Chamberlain JS; Maria BL
    J Child Neurol; 2010 Sep; 25(9):1080-97. PubMed ID: 20558673
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital muscular dystrophies.
    Kirschner J
    Handb Clin Neurol; 2013; 113():1377-85. PubMed ID: 23622361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is myoblast transplantation effective?
    Partridge T; Lu QL; Morris G; Hoffman E
    Nat Med; 1998 Nov; 4(11):1208-9. PubMed ID: 9809519
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene transfer establishes primacy of striated vs. smooth muscle sarcoglycan complex in limb-girdle muscular dystrophy.
    Durbeej M; Sawatzki SM; Barresi R; Schmainda KM; Allamand V; Michele DE; Campbell KP
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8910-5. PubMed ID: 12851463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted massively parallel sequencing and histological assessment of skeletal muscles for the molecular diagnosis of inherited muscle disorders.
    Nishikawa A; Mitsuhashi S; Miyata N; Nishino I
    J Med Genet; 2017 Feb; 54(2):104-110. PubMed ID: 27600705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immobility reduces muscle fiber necrosis in dystrophin deficient muscular dystrophy.
    Kimura S; Ikezawa M; Nomura K; Ito K; Ozasa S; Ueno H; Yoshioka K; Yano S; Yamashita T; Matuskura M; Miike T
    Brain Dev; 2006 Aug; 28(7):473-6. PubMed ID: 16516424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications.
    Serrano AL; Muñoz-Cánoves P
    Semin Cell Dev Biol; 2017 Apr; 64():181-190. PubMed ID: 27670721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha 2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi M; Kurahashi H; Noguchi S; Sese J; Okinaga T; Tsukahara T; Guicheney P; Ozono K; Nishino I; Morishita S; Toda T
    Biochem Biophys Res Commun; 2006 Apr; 342(2):489-502. PubMed ID: 16487936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 133rd ENMC International Workshop on Congenital Muscular Dystrophy (IXth International CMD Workshop) 21-23 January 2005, Naarden, The Netherlands.
    Muntoni F; Voit T
    Neuromuscul Disord; 2005 Nov; 15(11):794-801. PubMed ID: 16199159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.